Expression of blood group‐related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein Journal Article


Authors: Ichihara, T.; Sakamoto, J.; Nakao, A.; Furukawa, K.; Watanabe, T.; Suzuki, N.; Horisawa, M.; Nagura, H.; Lloyd, K. O.; Takagi, H.
Article Title: Expression of blood group‐related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein
Abstract: Background. Seven murine monoclonal antibodies (MoAb) detecting blood group antigens of the Lewis system and their sialylated derivatives were used to define their immunohistochemical distribution in normal and malignant pancreatic tissues. The specific blood group antigens studied included Lewis a (Le a ), Lewis b (Le b ), Lewis x (Le x ), Lewis y (Le y ), sialyl‐Lewis a (s‐Le a ), sialyllacto‐N‐tetraose (s‐LNT), and sialyl‐Lewis x (s‐Le x ). Methods. The expression of these antigens was analyzed by immunoperoxidase technique in pancreatic tissue of patients with (n = 27) and without (n = 19) pancreatic cancer. The genetic background of their secretor status and their Lewis phenotypes were determined by the enzyme‐linked immunosorbent assay using purified salivary glycoprotein and MoAb against eight different blood group–related antigens (Le a , Le b , Le x , Le y , H 1 , H 2 , A, B 2 ), and the putative genotypes of the patients were classified as follows: SeLe, Sele, seLe, and sele. Results. The following results were obtained: (1) In normal pancreas, Le a , s‐Le a , s‐LNT, and s‐Le x were expressed in ducts, but their expression was restricted to the luminal side of the cytoplasm (cytoplasmic type with positive polarity). Le b and Le y showed similar patterns of expression in ducts and some parts of the acinus. In contrast, Le x was absent in most cases. (2) Expression of Le b was observed in normal pancreatic ducts in all 46 patients, regardless of their genotypes. Le a and s‐Le a were not expressed in specimens from patients with the seLe and sele saliva phenotypes. (3) In pancreatic cancer, the following antigens were expressed cytoplasmically in the proportion of cases indicated: Le a (78%), Le b (85%), Le x (33%), Le y (44%), s‐Le a (78%), s‐LNT (89%), and s‐Le x (85%). They also were detected in the surrounding stroma. This pattern of expression is distinct from that found in normal pancreatic tissue. Patients with Sele and sele genotypes did not express Le a or s‐Le a , except in one case. (4) Serum levels of carbohydrate antigen 19‐9 (CA 19–9) were not elevated in patients with pancreatic cancer with the Sele and sele genotypes but were elevated in most patients with SeLe and seLe genotypes. Conclusion. The overall findings indicate that Lewis‐related antigens act as pancreatic tissue–related antigens, depending in part on salivary phenotypes of the patient. With proper antigen selection and the determination of secretor status, these anti–blood group MoAb may be of clinical utility in the diagnosis of pancreatic cancer. Cancer 1993; 71:71‐81. Copyright © 1993 American Cancer Society
Keywords: clinical article; controlled study; human tissue; pancreas cancer; pancreatic neoplasms; cancer diagnosis; pancreas; antigen expression; phenotype; genotype; enzyme linked immunosorbent assay; monoclonal antibody; antibodies, monoclonal; antigens, neoplasm; antibody specificity; pancreatic cancer; enzyme-linked immunosorbent assay; glycoprotein; lewis blood-group system; saliva analysis; saliva; blood group lewis system; blood group typing; human; priority journal; article; support, non-u.s. gov't; blood group antigen; blood group antibody; immuno‐histochemistry; secretor status
Journal Title: Cancer
Volume: 71
Issue: 1
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 1993-01-01
Start Page: 71
End Page: 81
Language: English
DOI: 10.1002/1097-0142(19930101)71:1<71::Aid-cncr2820710113>3.0.Co;2-4
PUBMED: 8416729
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kenneth O Lloyd
    163 Lloyd